The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
<iframe src="https://hindustansphere.com/embed/cluster/2a6e1e803d77e8a75f1b927ab5e2112c3067eaa2" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Dr. Reddy’s CDMO arm Aurigene inks long-term manufacturing pact with global pharma major"></iframe>
